Bacterial toxin may trigger multiple sclerosis onset and relapse cornell jclinicalinvest
Feil Family Brain and Mind Research Institute, Weill Cornell Medical College, New York, United States of AmericaJill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medical College, New York, United States of AmericaDepartment of Medicine, Weill Cornell Medical College, New York, United States of AmericaDepartment of Physiology and Biophysics, Institute for Computational Biomed, Weill Cornell Medical College, New York, United States of AmericaHarold and Margaret...
Department of Population Health Sciences, Weill Cornell Medical College, New york, United States of AmericaDepartment of Microbiology and Immunology, Weill Cornell Medical College, New York, United States of AmericaDepartment of Microbiology and Immunology, Weill Cornell Medical College, New York, NY 10065, United States of AmericaDepartment of Physiology and Biophysics, Weill Cornell Medical College, New York City, United States of AmericaFeil Family Brain and Mind Research Institute, Weill...
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Study details bacterial agents in 418 ticks extracted from humans in FranceIn a recent study published in the journal Emerging Infectious Diseases, researchers analyzed ticks that bit humans between January 2014 and March 2021 in France for the presence of bacterial pathogens.
Read more »
The tonsillitis symptom you can hear - and 10 other early warning signsTHE MAJORITY of people will catch tonsillitis at some point in their life – usually during childhood. It is usually caused by a viral infection or, less commonly, a bacterial infection. The t…
Read more »
Pneumolysin toxin holds promise for developing therapies against Streptococcus pneumoniaeIn a recent study published in the journal PLoS ONE, researchers in Spain performed a systematic review of pneumolysin (PLY) toxin as a molecular target to develop novel therapeutics against Streptococcus pneumoniae.
Read more »
Pneumolysin toxin holds promise for developing therapies against Streptococcus pneumoniaeIn a recent study published in the journal PLoS ONE, researchers in Spain performed a systematic review of pneumolysin (PLY) toxin as a molecular target to develop novel therapeutics against Streptococcus pneumoniae.
Read more »
Getting COVID-19 Could Weaken Your Immune SystemA study illustrates how SARS-CoV-2 can damage your immune response
Read more »